These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 9424756)
41. Alteration of T lymphocyte subpopulations in Swedish hemophiliacs. Biberfeld G; Blombäck M; Egberg N; Lenkei R; Nilsson IM; Porwit-Ksiazek A Scand J Haematol Suppl; 1984; 40():379-82. PubMed ID: 6332375 [No Abstract] [Full Text] [Related]
42. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beta 2-microglobulin-dependent and independent forms. Amano M; Baumgarth N; Dick MD; Brossay L; Kronenberg M; Herzenberg LA; Strober S J Immunol; 1998 Aug; 161(4):1710-7. PubMed ID: 9712035 [TBL] [Abstract][Full Text] [Related]
43. The effect of clotting factor concentrates on the immune system in HIV-negative haemophilics. Balkan C; Kavakli K; Kutukculer N; Aksu G; Yilmaz D; Aydinok Y Haemophilia; 2005 Jul; 11(4):366-70. PubMed ID: 16011589 [TBL] [Abstract][Full Text] [Related]
44. Issues surrounding therapeutic choices for hemophilia patients. Van den Berg HM Haematologica; 2004 Jun; 89(6):645-50. PubMed ID: 15194529 [No Abstract] [Full Text] [Related]
45. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy. Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546 [TBL] [Abstract][Full Text] [Related]
46. Sex hormones and peripheral white blood cell subsets in systemic lupus erythematosus patients. Rastin M; Hatef MR; Tabasi N; Sheikh A; Morad Abbasi J; Mahmoudi M Iran J Immunol; 2007 Jun; 4(2):110-5. PubMed ID: 17652851 [TBL] [Abstract][Full Text] [Related]
47. [Prevalence of HBs antigens and anti-HTLV antibodies in a population of 43 hemophiliacs]. Chouikha M; Bahri M; Amor A; Nooman S Tunis Med; 1987; 65(6-7):473-4. PubMed ID: 3505385 [No Abstract] [Full Text] [Related]
48. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood? Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A Eur J Cardiothorac Surg; 2006 Jul; 30(1):64-71. PubMed ID: 16730447 [TBL] [Abstract][Full Text] [Related]
50. [The populational structure of peripheral lymphocytes in patients in the acute phase of opisthorchiasis]. Kal'gina GA; Stepanova TF; Shonin AL Med Parazitol (Mosk); 2002; (1):16-8. PubMed ID: 12224257 [TBL] [Abstract][Full Text] [Related]
51. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX. Fields PA; Kowalczyk DW; Arruda VR; Armstrong E; McCleland ML; Hagstrom JN; Pasi KJ; Ertl HC; Herzog RW; High KA Mol Ther; 2000 Mar; 1(3):225-35. PubMed ID: 10933938 [TBL] [Abstract][Full Text] [Related]
52. Interview with Peter Lipsky. What is going to happen tomorrow as far as rheumatoid T and B cell subsets are concerned? Lipsky P Ann Med Interne (Paris); 1995; 146(2):111-3. PubMed ID: 7598334 [No Abstract] [Full Text] [Related]
53. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship. Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365 [TBL] [Abstract][Full Text] [Related]
54. [Galvanization of the area of the spleen as a method of immunocorrection in patients with chronic bronchitis]. Siurin SA Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (4):21-3. PubMed ID: 9424824 [TBL] [Abstract][Full Text] [Related]
55. [Plasmapheresis and immunocorrective therapy in the combined treatment of patients with pancreatic necrosis]. Zaĭtsev VT; Krivoruchko IA; Klimova EM; Gusak IV; Khizhniak AA; Shaposhnikov GA Klin Khir (1962); 1993; (11):3-5. PubMed ID: 8207905 [TBL] [Abstract][Full Text] [Related]
56. [The treatment of hemophilia in childhood]. Brüster H Ther Ggw; 1967 Jan; 106(1):44-50. PubMed ID: 6043575 [No Abstract] [Full Text] [Related]
57. [The use of immunotropic therapy in patients with systemic vasculitides]. Chop'iak VV Fiziol Zh (1994); 1997; 43(5-6):31-41. PubMed ID: 9463006 [TBL] [Abstract][Full Text] [Related]
58. Hemophilia management. United States Pharmacopeial Convention, Inc. Transfus Med Rev; 1998 Apr; 12(2):128-40. PubMed ID: 9566079 [No Abstract] [Full Text] [Related]